Revenue declined 5% Q-o-Q to SAR 24.81 billion, with adjusted EBITDA down 18% and an adjusted net loss of SAR 0.38 billion. All segments saw lower earnings, but Specialties showed resilient demand and pricing. Strategic divestments and growth projects progressed amid challenging market conditions.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.